期刊文献+

自身免疫性肝炎患者血清趋化因子水平与生物化学指标的相关性 被引量:10

Investigate circulating levels of chemokines and evaluate the correlation between these chemokines and liver function indicators in autoimmune hepatitis
原文传递
导出
摘要 目的探讨自身免疫性肝炎(AIH)患者外周血中趋化因子(CCL2、CCL5、CXCL8、CXCL9和CXCL10)水平及其与肝脏生物化学指标的相关陆。方法检测46例AIH患者血清中趋化因子(CCL2、CCL5、CXCL8、CXCL9和CXCL10)水平,选择12例健康体检者为对照组。结果AIH组CCL2、CXCL9和CXCL10水平分别为11.79pg/ml、11.31pg/ml和15.85pg/ml,高于健康对照组的8.39pg/ml、2.69pg/ml、4.64pg/ml,两组比较,z值分别为-1.958、4.527、-3.84,P值均〈0.05,差异均有统计学意义。AIH活动期组血清CCL2、CXCL8、CXCL9和CXCL10水平分别为29.69pg/ml、7.2pg/ml、16.02pg/ml和90.01pg/ml,明显高于激素治疗后缓解期组的11.16pg/ml、5.38pg/ml、5.47pg/ml、13.24pg/ml,两组比较,统计值分别为t=2.985、z=-2.547、z=-3.187、t=2.12,P值均〈0.05,差异均有统计学意义。AIH患者血清CXCL8与IgG水平呈正相关关系(r2=0.291,P〈0.05);CXCL9与ALT、AST水平均呈正相关关系(r2值分别为0.5324、0.3352,P值均〈0.05);CXCL10与ALT、AST、GGT水平均呈正相关关系(r2值分别为0.9551、0.8960、0.8271,P值均〈0.05)。结论活动期AIH患者外周血中CCL2、CXCL8、CXCL9和CXCL10水平明显升高,CXCL9和CXCL10水平与肝脏炎症活动指标呈明显正相关关系,提示趋化因子水平可反映AIH肝脏炎症活动程度,在AIH病理损伤中发挥重要作用。 Objective This study investigated circulation levels of chemokines (CCL2, CCL5, CXCL8, CXCL9, CXCL10) in autoimmune hepatitis(AIH) patients and evaluated the correlation between these chemokines and liver function indicators. Methods A total of 5 chemokines (CCL2, CCL5, CXCL8, CXCLg, CXCL10) were measured simultaneously by cytokine beads assay(CBA) in the sera of 46 patients with AIH and 12 cases of healthy control. Results In this study we found that serum levels of CCL2, CXCL9 and CXCL 10 in AIH patients and healthy controls were 11.79:8.39 pg/ml, 11.31:2.69 pg/ml, 15.85:4.64 pg/ ml, respectively, which implied these chemokines were significantly higher in AIH patients when compared to healthy control (Z=-1.958, P= 0.05; Z= -4.527, P 〈 0.0001; Z=-3.84, P 〈 0.0001, respectively). And circulation levels of CCL2, CXCL8, CXCL9 and CXCL10 in pretreatment and remission stages of patients with AIH were 29.69:11.16 pg/ml, 7.2:5.38 pg/ml, 16.02:5.47 pg/ml, 90.01:13.24 pg/ml, respectively, which showed these chemokines decreased during remission from pretreatment stage levels (t = 2.985, P = 0.005;Z= -2.547, P = 0.0112; Z= -3.187, P = 0.001; t = 2.12, P = 0.0015, respectively). Among AIH, CXCL8 was correlated positively with lgG(r2 = 0.291, P = 0.0039); CXCL9 was associated positively with ALT and AST(r2 = 0.5324, P 〈 0.0001; r2 = 0.3352, P 〈 0.0001); CXCL10 showed a positive correlation with ALT, AST and GGT(r2 = 0.9551,P〈 0.0001;r2 = 0.8960,P〈 0.0001;r2 = 0.8271,P 〈 0.0001). Conclusion Serum levels of CCL2, CXCL8, CXCL9 and CXCL10 are significantly higher in patients with AIH, but decrease to levels in healthy controls after successful treatment, and circulation levels of CXCL9 and CXCL10 are associated positively with liver function indicators which can react inflammation activity of liver, all these may imply that chemokines can reflect the degree of liver inflammation and may be one of the main culprits in AIH pathological damage.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2013年第4期299-303,共5页 Chinese Journal of Hepatology
基金 国家自然科学基金(81102265) 北京市自然科学基金(7111004) 北京市科委北京重大疾病临床数据和样本资源库建设基金(D09050703560903)
关键词 肝炎 自身免疫l性 趋化因子类 生物化学指标 相关性研究 Hepatitis, autoimmune Chemotactic factors Biochemical indicators Correlation analysis
  • 相关文献

参考文献9

  • 1Mieli-Vergani G, Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol, 2011, 8: 320-329.
  • 2Kamijo A, Yoshizawa K, Joshita S, et al. Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients. Hepatol Res, 2011, 41: 350-357.
  • 3Alvarez F, Berg PA, Bianch FB, et al. Intemational Autoimmune Hepatitis Group Report : review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31: 929-938.
  • 4赵艳,闫惠平,檀玉芬,冯霞,刘妍,崔丹,马冬梅,李伟华,张海萍.抗可溶性肝抗原/肝胰抗原抗体在自身免疫性肝炎诊断及分型中的意义[J].中华肝脏病杂志,2007,15(4):283-286. 被引量:26
  • 5Vergani D, Mieli-Vergani G. Autoimmune hepatitis. Minerva Gastxoenterol Dietol, 2004, 50:113-123.
  • 6Miiller-Hike B, Mitchison NA. The role of HLA promoters in autoimmunity. Curr Pharm Des, 2006, 12: 3743-3752.
  • 7Chuang YH, Lian ZX, Cheng CM, et al. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun, 2005, 25: 126-132.
  • 8Milks MW, Cripps JG, Lin H, et al. The role of Ifiag in alterations in liver gene expression in amouse model of fulminant autoimmune hepatitis. Liver Int, 2009, 29:1307-1315.
  • 9Longhi MS, Ma Y, Mieli-Vergani G, et al. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun, 2010, 34: 7-14.

二级参考文献13

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2刘燕敏,闫惠平,檀玉芬,刘妍,冯霞,孔淑玲.抗可溶性肝抗原/肝胰抗原抗体阳性的肝病患者临床与实验室特征[J].中华肝脏病杂志,2005,13(12):927-929. 被引量:2
  • 3Peters MG. Animal models of autoimmune liver disease. Immunol Cell Biol, 2002, 80:113-116.
  • 4Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31: 929-938.
  • 5Lohse AW, Gerken G, Mohr H, et al. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Z Gastroenterol, 1995, 33: 527-533.
  • 6Manns M, Gerken G, Kyriatsoulis A, et al. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet, 1987, 1 : 292-294.
  • 7Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet, 2000, 355: 1510-1515.
  • 8Czaja A J, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol, 2002, 97:413-419.
  • 9Herkel J, Heidrich B, Nieraad N, et al. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. Hepatology, 2002, 35: 403-408.
  • 10Czaja AJ, Homburger HA. Autoantibodies in liver disease. Gastroenterology, 2001, 120: 239-249.

共引文献25

同被引文献94

引证文献10

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部